Champions Oncology, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CSBR research report →
About the company
Champions Oncology, Inc. is dedicated to developing and commercializing cutting-edge technological products and services designed to personalize cancer treatment and streamline the development of oncology drugs across the United States. At the heart of its offerings is the Tumorgraft Technology Platform, an innovative approach that facilitates individualized cancer care by implanting human tumors into immune-deficient mice.
- CEO
- Robert Brainin
- IPO
- 2007
- Employees
- 210
- HQ
- Hackensack, NJ, US
Price Chart
- Market Cap
- $79.99M
- P/E
- -35.07
- P/S
- 1.38
- P/B
- 18.68
- EV/EBITDA
- -82.13
- Div Yield
- 0.00%
- Gross Margin
- 45.88%
- Op Margin
- -3.84%
- Net Margin
- -3.94%
- ROE
- -57.99%
- ROIC
- -23.16%
- Revenue
- $56.94M · 13.54%
- Net Income
- $4.70M · 164.61%
- EPS
- $0.34 · 162.96%
- Op Income
- $4.85M
- FCF YoY
- 200.34%
- 52W High
- $9.63
- 52W Low
- $5.50
- 50D MA
- $6.05
- 200D MA
- $6.36
- Beta
- 0.40
- Avg Volume
- 8.39K
Get TickerSpark's AI analysis on CSBR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 16, 25 | Brainin Robert Lawrence | other | 100,000 |
| Jul 16, 25 | Brainin Robert Lawrence | other | 100,000 |
| Jul 16, 25 | Brainin Robert Lawrence | other | 150,000 |
| Jul 16, 25 | Brainin Robert Lawrence | other | 62,500 |
| Jul 16, 25 | Brainin Robert Lawrence | other | 62,500 |
| Jul 16, 25 | Brainin Robert Lawrence | other | 225,000 |
| Nov 12, 24 | Brainin Robert Lawrence | other | 23,030 |
| Nov 3, 23 | Brainin Robert Lawrence | other | 19,070 |
| Nov 1, 22 | Brainin Robert Lawrence | other | 14,130 |
| Nov 5, 21 | Brainin Robert Lawrence | other | 9,901 |
Our CSBR coverage
Recent articles, reports, and earnings notes.
No research on CSBR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CSBR report →Similar companies
Peers in the same neighborhood.